New Type 2 Drugs Change Treatment Decisions

Metformin, the cornerstone in treating type 2 diabetes, saw an increase in usage among type 2s from 23 percent of that population in 1997 to 53 percent in 2012. But that increase has since plateaued due to the introduction of additional drugs that target insulin secretion and glucose regulation. DPP-4 inhibitors, such as Januvia and Onglyza, now account for 21 percent of treatments. Long-acting insulins,

Read more

My Pump Almost Killed Me… Twice

One of the greatest technological advancements in diabetes care has been the insulin pump.  For one, it gives you the illusion of being “normal” because you no longer have to inject insulin throughout the day. Instead, you “bolus” by pushing a button on the pump itself or using a remote control. It allows better glucose management because you can adjust your basal rate (the “background”

Read more